Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 1Rare Diseases 1Neuroblastoma 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Genetic Predisposition to Disease 1Breast Neoplasms 1

Interventions

posaconazole 1liposomal doxorubicin 1Vinorelbine 1Surveys and Questionnaires 1Prophylactic Mastectomy 1Multiparametric Magnetic Resonance Imaging 1Minoxidil 1High-Throughput Nucleotide Sequencing 1Fluconazole 1Exome 1Docetaxel 1Cephalexin 1Capecitabine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Genetic Predisposition to Disease × High-Throughput Nucleotide Sequencing × Clear all
NCT06060184 2023-09-29

IonGER

University Hospital Tuebingen

Phase NA Not yet recruiting
500 enrolled

Genetic Predisposition to Disease, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡